IL10 and type 1 diabetes mellitus: Sulfatide administration to NOD mice reduced T1D incidence and islet-specific T cell responses by inducing secretion of the anti-inflammatory cytokine IL-10 from DCs (48, 49), however, protection from T1D in NOD mice by sulfatide was not found in a second study (50).